New AI tool could revolutionize male fertility testing for IVF

NCT ID NCT07185984

Not yet recruiting Diagnosis Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to develop and validate an artificial intelligence tool that analyzes sperm quality using microfluidic technology. Researchers will test the tool on 200 men undergoing IVF or artificial insemination. The goal is to provide a more accurate, standardized diagnosis and recommend the best treatment, potentially improving success rates compared to current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SwimCount™ Harvester microfluidic system and AI-based diagnostic tool
What this could lead to: If successful, this could lead to a more accurate, personalized way to assess male fertility and select the best IVF treatment, potentially increasing pregnancy success rates.
What could go wrong: This is an early-stage validation study with 200 participants, so the tool may not prove accurate or beneficial in real-world settings. It also relies on existing technology and may not work for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY (IVF PATIENTS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder male infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY (IVF PATIENTS) MALE FERTILITY SPERM SELECTION

Contacts and locations

Locations

IVI Valencia

Valencia, 46015, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.